Gains and complex rearrangements of the 12q13-15 chromosomal region in ordinary lipomas: The "missing link" between lipomas and liposarcomas?

International Journal of Cancer

Volumn 121, Issue 2, 2007, Pages 308-315

  Italiano, Antoine ^a,b   Cardot, Nathalie ^a   Dupré, Florence ^c   Monticelli, Isabelle ^c   Keslair, Frédérique ^a   Piche, Marjorie ^a   Mainguené, Claire ^c   Coindre, Jean Michel ^d   Pedeutour, Florence ^a,e  

^a UNIVERSITY HOSPITAL OF NICE   (France)

^b CENTRE ANTOINE LACASSAGNE   (France)

^c CENTRE HOSPITALIER PRINCESSE GRACE   (Monaco)

^d INSTITUT BERGONIÉ   (France)

^e UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

Amplification; Chromosome 12; Lipoma; Rearrangement; Well differentiated liposarcoma

Indexed keywords

ARTICLE; CHROMOSOME 12Q; CHROMOSOME ABERRATION; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPOMA; LIPOSARCOMA; PRIORITY JOURNAL; TUMOR DIAGNOSIS;

AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 12; CYCLIN-DEPENDENT KINASE 4; FEMALE; HMGA2 PROTEIN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LIPOMA; LIPOSARCOMA; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-MDM2; TRANSLOCATION, GENETIC; TRISOMY;

EID: 34250310437     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22685     Document Type: Article

References (30)

1. Sandberg AA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: lipoma. Cancer Genet Cytogenet 2004;150:93-115.
2. Ashar HR, Fejzo MS, Tkachenko A, Zhou X, Fletcher JA, Weremowicz S, Morton CC, Chada K. Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 1995;82:57-65.
3. Schoenmakers EF, Wanschura S, Mols R, Bullerdiek J, Van den Berghe H, Van de Ven WJ. Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nat Genet 1995;10:436-44.
4. Fedele M, Battista S, Manfioletti G, Croce CM, Giancotti V, Fusco A. Role of the high mobility group A proteins in human lipomas. Carcinogenesis 2001;22:1583-91.
5. Nilbert M, Rydholm A, Willen H, Mitelman F, Mandahl N. MDM2 gene amplification correlates with ring chromosome in soil tissue tumors. Genes Chromosomes Cancer 1994;9:261-5.
6. Pedeutour F, Suijkerbuijk RF, Forus A, Van Gaal J, Van de Klundert W, Coindre JM, Nicolo G, Collin F, Van Haelst A, Huffermann K, Turc-Carel C. Complex composition and co-amplification of SAS and MDM2 in ring and giant rod marker chromosomes in well-differentiated liposarcoma. Genes Chromosomes Cancer 1994;10:85-94.
7. Szymanska J, Tarkkanen M, Wiklund T, Virolainen M, Blomqvist C, Asko-Seljavaara S, Tukiainen E, Elomaa I, Knuutila S. Gains and losses of DNA sequences in liposarcomas evaluated by comparative genomic hybridization. Genes Chromosomes Cancer 1996;15:89-94.
8. Pedeutour F, Forus A, Coindre J-M, Berner J-M, Nicolo G, Michiels J-F, Terrier P, Ranchere-Vince D, Collin F, Myklebost O, Turc-Carel C. Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. Genes Chromosomes Cancer 1999;24:30-41.
9. Binh MB, Sastre-Garau X, Guillou L, de Pinieux G, Terrier P, Lagace R, Aurias A, Hostein I, Coindre JM. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data. Am J Surg Pathol 2005;29:1340-7.
10. Sirvent N, Forus A, Lescaut W, Burel F, Benzaken S, Chazal M, Bourgeon A, Vermeesch JR, Myklebost O, Turc-Carel C, Ayraud N, Coindre JM, Pedeutour F. Characterization of centromere alterations in liposarcomas. Genes Chromosomes Cancer 2000;29:117-29.
11. Amor DJ, Choo KH. Neocentromeres: role in human disease, evolution, and centromere study. Am J Hum Genet 2002;71:695-714.
12. Mandahl N, Akerman M, Aman P, Dal Cin P, De Wever I, Fletcher CD, Mertens F, Mitelman F, Rosai J, Rydholm A, Sciot R et al.Duplication of chromosome segment 12q15-24 is associated with atypical lipomatous tumors: a report of the CHAMP collaborative study group. CHromosomes And MorPhology. Int J Cancer 1996;67:632-5.
13. Storlazzi CT, Mertens F, Domanski H, Fletcher CD, Wiegant J, Mandahl N. Ring chromosomes and low-grade gene amplification in an atypical lipomatous tumor with minimal nuclear atypia. Int J Oncol 2003;23:67-71.
14. Dei Tos AP, Doglioni C, Piccinin S, Sciot R, Furlanetto A, Boiocchi M, Dal Cin P, Maestro R, Fletcher CD, Tallini G. Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours. J Pathol 2000;190:531-6.
15. Fletcher C, Unni K, Mertens F. Pathology and genetics of tumours of soft tissue and bone. Oxford: Oxford University Press, 2002.
16. Limon J, Dal Cin P, Sandberg AA. Application of long-term collagenase disaggregation for the cytogenetic analysis of human solid tumors. Cancer Genet Cytogenet 1986;23:305-13.
17. Merscher S, Marondel I, Pedeutour F, Gaudray P, Kucherlapati R, Turc-Carel C. Identification of new translocation breakpoints at 12q13 in lipomas. Genomics 1997;46:70-7.
18. Mentzel T. Biological continuum of benign, atypical, and malignant mesenchymal neoplasms - does it exist? J Pathol 2000;190:523-5.
19. Gisselsson D, Höglund M, Mertens F, Mandahl N. Variable stability of chromosomes containing amplified alpha-satellite sequences in human mesenchymal tumors. Chromosoma 1999;108:271-277.
20. Forus A, Bjerkehagen B, Sirvent N, Meza-Zepeda LA, Coindre JM, Berner JM, Myklebost O, Pedeutour F. A well-differentiated liposarcoma with a new type of chromosome 12-derived markers. Cancer Genet Cytogenet 2001;131:13-18.
21. Ciullo M, Debily MA, Rozier L, Autiero M, Billault A, Mayau V, El Marhomy S, Guardiola J, Bernheim A, Coullin P, Piatier-Tonneau D, Debatisse M. Initiation of the breakage-fusion-bridge mechanism through common fragile site activation in human breast cancer cells: the model of PIP gene duplication from a break at FRA7I. Hum Mol Genet 2002;11:2887-94.
22. Hellman A, Zlotorynski E, Scherer SW, Cheung J, Vincent JB, Smith DI, Trakhtenbrot L, Kerem B. A role for common fragile site induction in amplification of human oncogenes. Cancer Cell 2002;1:89-97.
23. Myllykangas S, Knuutila S. Manifestation, mechanisms and mysteries of gene amplifications. Cancer Lett 2006;232:79-89.
24. Schoenberg Fejzo M, Ashar HR, Krauter KS, Powell WL, Rein MS, Weremowicz S, Yoon SJ, Kucherlapati RS, Chada K, Morton CC. Translocation breakpoints upstream of the HMGIC gene in uterine leiomyomata suggest dysregulation of this gene by a mechanism different from that in lipomas. Genes Chromosomes Cancer 1996; 17:1-6.
25. Dal Cin P, Thomas A, Weremowicz S. An intragenic rearrangement of HMGA2 is not necessary for lipoma formation. Cancer Genet Cytogenet 2004;149:178-9.
26. Berner JM, Meza-Zepeda LA, Kools PF, Forus A, Schoenmakers EF, Van de Ven WJ, Fodstad O, Myklebost O. HMGIC, the gene for an architectural transcriptionfactor, is amplified and rearranged in a subset of human sarcomas. Oncogene 1997;14:2935-41.
27. Pentimalli F, Dentice M, Fedele M, Pierantoni GM, Cito L, Pallante P, Santoro M, Viglietto G, Dal Cin P, Fusco A. Suppression of HMGA2 protein synthesis could be a tool for the therapy of well differentiated liposarcomas overexpressing HMGA2. Cancer Res 2003; 63:7423-7.
28. Meza-Zepeda LA, Berner JM, Henriksen J, South AP, Pedeutour F, Dahlberg AB, Godager LH, Nizetic D, Forus A, Myklebost O. Ectopic sequences from truncated HMGIC in liposarcomas are derived from various amplified chromosomal regions. Genes Chromosomes Cancer 2001;31:264-73.
29. Hisaoka M, Sheng WQ, Tanaka A, Hashimoto H. HMGIC alterations in smooth muscle tumors of soft tissues and other sites. Cancer Genet Cytogenet 2002;138:50-5.
30. Cho YL, Bae S, Koo MS, Kim KM, Chun HJ, Kim CK, Ro DY, Kim JH, Lee CM, Kim YW, Ahn WS. Array comparative genomic hybridization analysis of uterine leiomyosarcoma. Gynecol Oncol 2005;99: 545-51.